|
⚲
|
| Keyboard |
| David McElligott | |
|---|---|
| Firm | |
| Address | c/o Petra Pharma Corporation 450 E 29th St, Suite 506 New York, NY 10016 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Petra Pharma Corp | 021-321233 | Executive Officer | 27.5 M of 27.5 M |
||
| Apogen Biotechnologies Inc | 021-275911 | Executive Officer | 7.6 M of 7.6 M |
||
| Petra Pharma Corp | 021-254662 | Executive Officer | 31.2 M of 48.2 M |
||
| LODO Therapeutics Corp | 021-254438 | Executive Officer | 19.9 M of 19.9 M |
||
| Oncofactor Corp | 021-202194 | Executive Officer | 1.0 M of 6.0 M |
||